Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibrentasvir

被引：0
作者：
Quintero Garcia, Diannet [1 ]
Sebastian Cuevas, Francisco Jose [1 ]
Crehua Gaudiza, Elena [1 ]
机构：
[1] Hosp Clin Univ Valencia, Dept Pediat, Valencia, Spain
来源：
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS | 2021年 / 113卷 / 02期
关键词：
Children; Hepatitis C virus; Beta-thalassemia major; Cirrhosis; Glecaprevir/pibrentasvir;
D O I：
10.17235/reed.2020.7092/2020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatitis C virus (HCV) is estimated to affect 3.26 million children worldwide, with the highest number of cases registered in Pakistan and China. Vertical transmission is the principal route in industrialized countries. However, iatrogenic transmission is relevant in low-income settings. We present the case of a 12-year-old Pakistani child who suffered from beta-thalassemia major and hepatitis C, successfully treated with glecaprevir/pibrentasvir.
引用
收藏
页码：150 / +
页数：2
相关论文
共 6 条
  • [1] Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
    Crespo, Javier
    Albillos, Agustin
    Buti, Maria
    Luis Calleja, Jose
    Garcia Samaniego, Javier
    Hernandez Guerra, Manuel
    Serrano, Trinidad
    Turnes, Juan
    Acin, Enrique
    Berenguer, Juan
    Berenguer, Marina
    Colom, Joan
    Fernandez, Inmaculada
    Fernandez Rodriguez, Conrado
    Forns, Xavier
    Garcia, Federico
    Granados, Rafael
    Lazarus, Jeffrey
    Maria Molero, Jose
    Molina, Esther
    Perez Escanilla, Fernando
    Pineda, Juan A.
    Rodriguez, Manuel
    Romero, Manuel
    Roncero, Carlos
    Saiz de la Hoya, Pablo
    Sanchez Antolin, Gloria
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (11) : 862 - 873
  • [2] Indolfi G, 2019, LANCET GASTROENTEROL, V4, P477, DOI 10.1016/S2468-1253(19)30046-9
  • [3] Jonas MM, 2020, HEPATOLOGY, V71, P456, DOI [10.1002/hep.30840/suppinfo, 10.1002/hep.30840]
  • [4] The Course of Hepatitis C Infection and Response to Anti-viral Therapy in Patients with Thalassemia major and Hepatitis C Infection: A Longitudinal, Prospective Study
    Kamal, Sanaa
    Abdelhakam, Sara
    Ghoraba, Dalia
    Mohsen, Mohamed Amer
    Salam, Ahmed Abdel
    Hassan, Hoda
    Nabeigh, Leila
    [J]. MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2019, 11
  • [5] Guidelines for the prevention of intravascular catheter-related infections
    O'Grady, NP
    Alexander, M
    Dellinger, EP
    Gerberding, JL
    Heard, SO
    Maki, DG
    Masur, H
    McCormick, RD
    Mermel, LA
    Pearson, ML
    Raad, II
    Randolph, A
    Weinstein, RA
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2002, 23 (12) : 759 - 769
  • [6] Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial
    Wyles, David
    Poordad, Fred
    Wang, Stanley
    Alric, Laurent
    Felizarta, Franco
    Kwo, Paul Y.
    Maliakkal, Benedict
    Agarwal, Kosh
    Hassanein, Tarek
    Weilert, Frank
    Lee, Samuel S.
    Kort, Jens
    Lovell, Sandra S.
    Liu, Ran
    Lin, Chih-Wei
    Pilot-Matias, Tami
    Krishnan, Preethi
    Mensa, Federico J.
    [J]. HEPATOLOGY, 2018, 67 (02) : 514 - 523
1